News
Stay up-to-date with our latest news, announcements and more
8 Results
Enhancing pediatric access to cell and gene therapies
This perspective proposes the creation of a new entity, the Pediatric Advanced Medicines Biotech, to lead late-stage development and commercialize…
Enabling access to genetically modified cell therapies
This commentary outlines strategies to streamline regulatory pathways and enable timely, sustainable access to genetically modified cell therapies for small…
CAR T cells: improving outcomes for children with cancer
CAR T cells hold great promise for improving outcomes for children with cancer, but additional research and new business models…
ACCESSforKIDS: A new model to pay for pediatric cell and gene therapies
Meet the team forming ACCESSforKIDS, a nonprofit whose mission is to build new pathways to pay for cures and provide…
FDA Roundtable: Cath Bollard
FDA Roundtable: Crystal Mackall
FDA Roundtable: Cath Bollard and Crystal Mackall
Closer to Cures: Crystal Mackall
Crystal Mackall discusses the GD2-CART Cells for Diffuse Midline Gliomas as part of the California Institute for Regenerative Medicine (CIRM)…